Joseph G. Schroers‐Martin

Author

Also Known As

J Schroers-Martin, J. G. Schroers‐Martin, J. Schroers-Martin, J. Schroers‐Martin, Joe Schroers-Martin, Joseph G Schroers-Martin, Joseph G. Schroers-Martin, Joseph G. Schroers‐Martin, Joseph Schroers-Martin, Joseph Schroers‐Martin

121

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Stanford University California Institute for Regenerative Medicine Stanford Medicine The University of Texas MD Anderson Cancer Center Stanford Cancer Institute

About

Joseph G. Schroers‐Martin is an author at Stanford University specializing in medicine, cancer research, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.7K
2	Cell Biology	3	3	357
3	Engineering	1	1	655
4	Health Sciences	1	1	332
5	Natural Sciences	1	1	197

Joseph G. Schroers‐Martin

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Integrating genomic features for non-invasive early lung cancer detection Jacob J. Chabon, Emily G. Hamilton, David M. Kurtz, Nature EngineeringCancer DetectionGenomic FeaturesMedicineMultiple Pulmonary Nodule	2020	655
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA David M. Kurtz, Joanne Soo, Lyron Co Ting Keh, Nature Biotechnology OncologyEnhanced DetectionSomatic VariantTumor HeterogeneityMedicine	2021	332
Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer Tej D. Azad, Aadel A. Chaudhuri, Penny Fang, Gastroenterology Tumor Dna AnalysisEsophageal CancerCancer DetectionMedicinePathology	2019	267
Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Jonathan C. Dudley, Joseph G. Schroers‐Martin, Daniel Lazzareschi, Cancer Discovery	2018	223
Inferring gene expression from cell-free DNA fragmentation profiles Mohammad Shahrokh Esfahani, Emily G. Hamilton, Mahya Mehrmohamadi, Nature Biotechnology Functional GenomicsNatural SciencesGene RecognitionDna AnalysisDna Replication	2022	197
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas Brian J. Sworder, David M. Kurtz, Stefan Alig, Cancer Cell Lymphoid NeoplasiaCancer ImmunosurveillanceMedicineImmunologyAutoimmunity	2022	119
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling Stefan Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, Nature Lymphoid NeoplasiaNoninvasive Genomic ProfilingMedicineImmunologyPathology	2023	87
CD20-Targeted Therapy Ablates <i>De Novo</i> Antibody Response to Vaccination but Spares Preestablished Immunity Tanaya Shree, Vishnu Shankar, Julian J.K. Lohmeyer, Blood Cancer Discovery	2022	47
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment Jenna M. Kastenschmidt, Joseph G. Schroers‐Martin, Brian J. Sworder, Cell stem cell ImmunologyPathologyImmunotherapeuticsImmune Cell TherapyImmunotherapy	2024	41
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors Joseph G. Schroers‐Martin, Joanne Soo, Gabriel Brisou, Cancer Discovery	2023	30

Page 1